| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.5 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.5 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |